Tsuguhito Ota

9.6k citations

86 papers · 6.8k indexed · 2 hit papers · h-index 45

Epidemiology top 0.5%
Molecular Biology top 5%
Endocrinology, Diabetes and Metabolism top 0.5%
Physiology top 1%
Surgery top 2%

Co-authors: Naoto Nagata Yinhua Ni Shuichi Kaneko Toshinari Takamura Liang Xu Mayumi Nagashimada Hitoshi Ando Hirofumi Misu
Topics: Liver Disease Diagnosis and Treatment (34 papers)Adipose Tissue and Metabolism (21 papers)Adipokines, Inflammation, and Metabolic Diseases (15 papers)
Cited by: Endocrinology, Diabetes and Metabolism Epidemiology Hepatology
Journals: Journal of Biological Chemistry Journal of Clinical InvestigationSHILAP Revista de lepidopterología
Partner nations: Japan United States China

In The Last Decade

Tsuguhito Ota

86 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice

2017 402 citations Liang Xu, Naoto Nagata et al. EBioMedicine profile →
Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments

2017 383 citations Guanliang Chen, Yinhua Ni et al. profile →

Peers

Countries citing papers authored by Tsuguhito Ota

Since Specialization

Citations

This map shows the geographic impact of Tsuguhito Ota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsuguhito Ota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsuguhito Ota more than expected).

Fields of papers citing papers by Tsuguhito Ota

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsuguhito Ota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsuguhito Ota. The network helps show where Tsuguhito Ota may publish in the future.

Co-authorship network of co-authors of Tsuguhito Ota

This figure shows the co-authorship network connecting the top 25 collaborators of Tsuguhito Ota. A scholar is included among the top collaborators of Tsuguhito Ota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsuguhito Ota. Tsuguhito Ota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Brown adipocyte-specific knockout of Bmal1 causes mild but significant thermogenesis impairment in mice 2021 ·Molecular Metabolism ·(unknown),Naoto Nagata,Jun‐ichi Morishige,Md Tarikul Islam,(unknown),Kenichi Harada,Michihiro Mieda,Masanori Ono,Hiroshi Fujiwara,Takiko Daikoku,Tomoko Fujiwara,Yoshiko Maida,Tsuguhito Ota,Shigeki Shimba,Shuichi Kaneko,Akio Fujimura,Hitoshi Ando	26
2	Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in mice 2020 ·Scientific Reports ·(unknown),Naoto Nagata,Tetsuro Shimakami,Takashi Shirakura,Chieko Matsui,Yinhua Ni,Fen Zhuge,Liang Xu,Guanliang Chen,Mayumi Nagashimada,Taro Yamashita,Yoshio Sakai,Tatsuya Yamashita,Eishiro Mizukoshi,Masao Honda,Shuichi Kaneko,Tsuguhito Ota	57
3	Increment of plasma glucose by exogenous glucagon is associated with present and future renal function in type 2 diabetes:a retrospective study from glucagon stimulation test 2019 ·BMC Endocrine Disorders ·Yasutaka Takeda,Yukihiro Fujita,(unknown),(unknown),(unknown),(unknown),Hidemitsu Sakagami,Atsuko Abiko,Yumi Takiyama,Tsuguhito Ota,Masakazu Haneda	4
4	Impacts of Diabetes and an SGLT2 Inhibitor on the Glomerular Number and Volume in db/db Mice, as Estimated by Synchrotron Radiation Micro-CT at SPring-8 2018 ·EBioMedicine ·Yumi Takiyama,Toshihiro Sera,Masanori Nakamura,(unknown),Yasuaki Saijo,(unknown),(unknown),(unknown),(unknown),(unknown),Hidemitsu Sakagami,(unknown),Yukihiro Fujita,Yuichi Makino,Atsuko Abiko,Masato Hoshino,Kentaro Uesugi,Naoto Yagi,Tsuguhito Ota,Masakazu Haneda	29
5	β-クリプトキサンチンはマウスのミトコンドリア機能不全を減弱することによるアスタキサンチンより心臓虚血-再潅流障害に対する大心臓保護効果を発揮する【Powered by NICT】 2017 ·Molecular Nutrition & Food Research ·(unknown),(unknown),(unknown),(unknown),Naoto Nagata,(unknown),Soichiro Usui,(unknown),Masayuki Takamura,(unknown),(unknown),Tsuguhito Ota	1
6	BETA-CRYPTOXANTHIN EXERTS BETTER CARDIOPROTECTION AGAINST CARDIAC ISCHEMIA-REPERFUSION INJURY THAN ASTAXANTHIN VIA PROTECTING MITOCHONDRIAL DYSFUNCTION IN MICE 2017 ·Journal of the American College of Cardiology ·Wanpitak Pongkan,Liang Xu,(unknown),Naoto Nagata,Yinhua Ni,(unknown),Siriporn C. Chattipakorn,Soichiro Usui,Tsuguhito Ota,Nipon Chattipakorn	1
7	Peretinoin, an acyclic retinoid, inhibits hepatocarcinogenesis by suppressing sphingosine kinase 1 expression in vitro and in vivo 2017 ·Scientific Reports ·(unknown),(unknown),Tetsuro Shimakami,Naoto Nagata,(unknown),(unknown),Hikari Okada,(unknown),Takayoshi Shirasaki,Takeru Oyama,Taro Yamashita,Tsuguhito Ota,Yoh Takuwa,Masao Honda,Shuichi Kaneko	29
8	Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E 2015 ·Scientific Reports ·Yinhua Ni,Mayumi Nagashimada,Fen Zhuge,(unknown),Naoto Nagata,Akemi Tsutsui,Yasuni Nakanuma,Shuichi Kaneko,Tsuguhito Ota	212
9	Obesity-Induced Inflammation and Insulin Resistance 2014 ·Frontiers in Endocrinology ·Tsuguhito Ota	33
10	The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial 2014 ·Diabetologia ·Yumie Takeshita,Toshinari Takamura,Masao Honda,Yuki Kita,Yoh Zen,Kenichiro Kato,Hirofumi Misu,Tsuguhito Ota,Mikiko Nakamura,Kazutoshi Yamada,Hajime Sunagozaka,Kuniaki Arai,Tatsuya Yamashita,Eishiro Mizukoshi,Shuichi Kaneko	98
11	Effect of pioglitazone on muscle sympathetic nerve activity in type 2 diabetes mellitus with alpha-glucosidase inhibitor 2010 ·Autonomic Neuroscience ·Daisuke Kobayashi,Masayuki Takamura,Hisayoshi Murai,Soichiro Usui,Tatsunori Ikeda,(unknown),Shinichiro Takashima,Takeshi Kato,Hiroshi Furusho,Yumie Takeshita,Tsuguhito Ota,Toshinari Takamura,Shuichi Kaneko	22
12	Palmitate Induces Insulin Resistance in H4IIEC3 Hepatocytes through Reactive Oxygen Species Produced by Mitochondria 2009 ·Journal of Biological Chemistry ·Seiji Nakamura,Toshinari Takamura,Naoto Nagata,Hiroaki Takayama,Hirofumi Misu,(unknown),(unknown),Seiichiro Kurita,Tsuguhito Ota,Hitoshi Ando,Ken‐ichi Miyamoto,Shuichi Kaneko	364
13	Obesity Upregulates Genes Involved in Oxidative Phosphorylation in Livers of Diabetic Patients 2008 ·Obesity ·Toshinari Takamura,Hirofumi Misu,Naoto Nagata,Masaru Sakurai,Tsuguhito Ota,Akiko Shimizu,Seiichiro Kurita,Yumie Takeshita,Hitoshi Ando,Masao Honda,Shuichi Kaneko	78
14	Liver steatosis, but not fibrosis, is associated with insulin resistance in nonalcoholic fatty liver disease 2007 ·Journal of Gastroenterology ·Masaru Sakurai,Toshinari Takamura,Tsuguhito Ota,Hitoshi Ando,Hiroshi Akahori,Kyosuke Kaji,Motoko Sasaki,Yasuni Nakanuma,Katsuyuki Miura,Shuichi Kaneko	39
15	Gene expression profiles in peripheral blood mononuclear cells reflect the pathophysiology of type 2 diabetes 2007 ·Biochemical and Biophysical Research Communications ·Toshinari Takamura,Masao Honda,Yoshio Sakai,Hitoshi Ando,Akiko Shimizu,Tsuguhito Ota,Masaru Sakurai,Hirofumi Misu,Seiichiro Kurita,Naoto Nagata,(unknown),Seiji Nakamura,Ryo Matoba,Motohiko Tanino,Kenichi Matsubara,Shuichi Kaneko	59
16	Tumor necrosis factor-α–induced production of plasminogen activator inhibitor 1 and its regulation by pioglitazone and cerivastatin in a nonmalignant human hepatocyte cell line 2006 ·Metabolism ·Yumie Takeshita,Toshinari Takamura,(unknown),Akiko Shimizu,Tsuguhito Ota,Masaru Sakurai,Shuichi Kaneko	27
17	Genes involved in oxidative phosphorylation are coordinately upregulated with fasting hyperglycaemia in livers of patients with type 2 diabetes 2006 ·Diabetologia ·Hirofumi Misu,Toshinari Takamura,(unknown),Akiko Shimizu,Tsuguhito Ota,Masaru Sakurai,Hitoshi Ando,Kuniaki Arai,Taro Yamashita,Masao Honda,Takeshi Yamashita,Shuichi Kaneko	73
18	Tranilast Prevents the Progression of Experimental Diabetic Nephropathy through Suppression of Enhanced Extracellular Matrix Gene Expression 2005 ·Journal of Pharmacology and Experimental Therapeutics ·Hiroshi Akahori,Tsuguhito Ota,(unknown),Hitoshi Ando,Shuichi Kaneko,Toshinari Takamura	19
19	Genes for systemic vascular complications are differentially expressed in the livers of Type 2 diabetic patients 2004 ·Diabetologia ·Toshinari Takamura,Masaru Sakurai,Tsuguhito Ota,Hitoshi Ando,Shuichi Kaneko,Masayuki Honda	50
20	Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model 2003 ·Diabetologia ·Tsuguhito Ota,Toshinari Takamura,Hitoshi Ando,(unknown),Haruhisa Yamashita,Kenichi Kobayashi	83

About Tsuguhito Ota

Tsuguhito Ota is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Biochemistry, having authored 86 papers that have together received 6.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (34 papers), Adipose Tissue and Metabolism (21 papers) and Adipokines, Inflammation, and Metabolic Diseases (15 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.8k citations), Epidemiology (3.2k citations) and Hepatology (553 citations). Tsuguhito Ota has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Naoto Nagata, Yinhua Ni, Shuichi Kaneko, Toshinari Takamura, Liang Xu, Mayumi Nagashimada, Hitoshi Ando, Hirofumi Misu, Guanliang Chen and Seiichiro Kurita. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact